生命科学资讯

Morgan Stanley Initiates Agilent Technologies at Overweight With $180 Price Target - MarketScreener

Human Single-Cell Multi-Omics Market Set for Rapid Growth, - openPR.com

Why Waters Corporation stock stays resilient - Wall Street Watch & Risk Managed Trade Strategies - Newser

Can Agilent Technologies Inc. stock test all time highs - 2025 Breakouts & Breakdowns & AI Forecast for Swing Trade Picks - Newser

India could scale semiconductor manufacturing faster than expected, says Thermo Fisher leaders - ET Manufacturing

Why Waters Corporation stock remains undervalued - Gap Up & Free Fast Entry Momentum Trade Alerts - Newser

Will Waters Corporation (WAZ) stock announce a stock split - Options Play & Safe Capital Investment Plans - Newser

Agilent Technologies (NYSE:A) VP Sells $464,970.00 in Stock - MarketBeat

Thermo Fisher expands bioprocessing capabilities across Asia - Investing.com

Thermo Fisher (TMO) boosts Asia biopharma support with new and expanded design centers - Stock Titan

Genetic testing transformed her cancer care—and her family tree - Illumina

Hospitals challenge 340B rebate pilot program in Maine federal court

Middle East Cell and Gene Therapy CDMO Market Forecast to 2033 Featuring Strategic Profiles of Key P - PharmiWeb.com

Pentagon seeks to add WuXi AppTec to military list: report

New York judge revives Bristol Myers dispute over Celgene deal

Janux T-cell engager data sink stock, but analysts still see best-in-class potential

FDA issues draft guidance to reduce primate testing for certain antibodies

Boston Scientific claims European approval for Farapoint focal pulsed field ablation catheter

CDER head Richard Pazdur set to retire shortly after appointment

FDA to remove some monkey testing from monoclonal antibody development